Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
Reads0
Chats0
TLDR
Yeast microcapsule-mediated oral delivery of IL-1β shRNA may serve as a novel gene therapy strategy for treating joint degeneration through immunomodulation of the mononuclear phagocyte system from the intestine to subchondral bone marrow and ultimately preserving the articular cartilage joint.Abstract:
Post-traumatic osteoarthritis is a prevalent debilitating joint disease. However, there is no FDA-approved disease-modifying osteoarthritis drug currently. Gene therapy can improve disease progression but lacks an effective delivery system. Here, we constructed an oral drug delivery system by non-virus-mediated interleukin-1β (IL-1β) short hairpin RNA (shRNA) and non-pathogenic yeast to evaluate its effect on osteoarthritis therapy. After recombinant IL-1β shRNA/yeast therapy, yeast microcapsule-mediated oral delivery of IL-1β shRNA greatly reduced the IL-1β expression in intestine macrophage, bone marrow macrophage, and articular cartilage, systematically regulate the inflammatory response. The degeneration of articular cartilage was significantly inhibited in the medial femoral condyle and medial tibial plateau of the knee joint. And the expression of osteoarthritis markers Col X and MMP13 was reduced in the knee joint. Thus, yeast microcapsule-mediated oral delivery of IL-1β shRNA may serve as a novel gene therapy strategy for treating joint degeneration through immunomodulation of the mononuclear phagocyte system from the intestine to subchondral bone marrow and ultimately preserving the articular cartilage joint.read more
Citations
More filters
Journal ArticleDOI
Complex molecular mechanism of ammonia-induced apoptosis in chicken peripheral blood lymphocytes: miR-27b-3p, heat shock proteins, immunosuppression, death receptor pathway, and mitochondrial pathway.
TL;DR: Wang et al. as discussed by the authors established an ammonia poisoning model of chicken peripheral blood lymphocytes (PBLs) to explore poisoning mechanism of ammonia-caused apoptosis in chicken PBLs.
Journal ArticleDOI
Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport.
Yang-Bao Miao,Yu-Jung Lin,Chen Kuan-Hung,Po-Kai Luo,Shun-Hao Chuang,Yu-Tzu Yu,Hsien-Meng Tai,Chiung-Tong Chen,Kun-Ju Lin,Hsing-Wen Sung +9 more
TL;DR: In this paper, the authors describe the anatomical structures and physiological characteristics of the intestinal lymphatic system (ILS), with an emphasis on enterocytes and microfold (M) cells, which are the main gateways for the transport of particulate delivery vehicles across the intestinal epithelium into the lymphatics.
Journal ArticleDOI
Yeast as carrier for drug delivery and vaccine construction.
TL;DR: A conceptual description of gastrointestinal absorption of yeast carriers, as well as the various package forms of different drug molecules and nanoparticles in yeast carriers are introduced.
Journal ArticleDOI
Yeast Microcapsule Mediated Natural Products Delivery for Treating Ulcerative Colitis through Anti-Inflammatory and Regulation of Macrophage Polarization.
Xingxing Feng,Qingguo Xie,Hongbo Xu,Tiantian Zhang,Xiaonan Li,Yinmei Tian,Hongbing Lan,Li Kong,Zhiping Zhang +8 more
TL;DR: This BBR/MPN@YM targeted oral drug delivery system provided a new macrophages-targeting strategy for the clinical treatment of UC.
Journal ArticleDOI
Yeasts in nanotechnology-enabled oral vaccine and gene delivery.
TL;DR: Yeast capsules can stimulate and modulate host immune responses, which is beneficial for vaccine efficacy as discussed by the authors, and recombinant modification of Yeasts to express cell penetrating proteins and injection mechanisms along with efficient cell adhering capabilities can potentially improve transfection rates of genetic material.
References
More filters
Journal ArticleDOI
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse
TL;DR: A semi-quantitative scoring system that can be applied universally to instability, enzymatic, transgenic and spontaneous OA models may be a useful tool for both new and experienced scorers to sensitively evaluate models and OA mechanisms, and also provide a common paradigm for comparative evaluation across the many groups performing these analyses.
Journal ArticleDOI
The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.
TL;DR: The cytokine network in OA is put in the context of cells involved in this degenerative joint disease and the possibilities for further implementation of new therapeutic strategies are pointed.
Journal ArticleDOI
Second-generation shRNA libraries covering the mouse and human genomes.
Jose M. Silva,Mamie Z. Li,Kenneth Chang,Wei Ge,Michael C. Golding,Richard J. Rickles,Despina Siolas,Guang Hu,Patrick J. Paddison,Michael R. Schlabach,Nihar U. Sheth,Jeff Bradshaw,Julia Burchard,Amit A. Kulkarni,Guy Cavet,Ravi Sachidanandam,W. Richard McCombie,Michele A. Cleary,Stephen J. Elledge,Gregory J. Hannon +19 more
TL;DR: Large-scale-arrayed, sequence-verified libraries comprising more than 140,000 second-generation short hairpin RNA expression plasmids, covering a substantial fraction of all predicted genes in the human and mouse genomes are generated.
Journal ArticleDOI
Oral tolerance to food protein
Oliver Pabst,Allan McI. Mowat +1 more
TL;DR: A model of stepwise induction of oral tolerance is proposed in which specialized populations of mucosal dendritic cells and the unique microenvironment of draining mesenteric lymph nodes combine to generate regulatory T cells that undergo subsequent expansion in the small intestinal lamina propria.
Journal ArticleDOI
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Myriam Aouadi,Gregory J. Tesz,Sarah M. Nicoloro,Mengxi Wang,My T. Chouinard,Ernesto Soto,Gary R. Ostroff,Michael P. Czech +7 more
TL;DR: The engineering of β1,3-d-glucan-encapsulated siRNA particles (GeRPs) are reported as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo, defining a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.
Related Papers (5)
Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model.
Rachael S. Watson Levings,Ted A. Broome,Andrew D. Smith,Rice B,Eric P. Gibbs,David A. Myara,E. Viktoria Hyddmark,Elham Nasri,Ali Zarezadeh,Padraic P. Levings,Yuan Lu,Margaret E. White,E. Anthony Dacanay,Gregory B. Foremny,Christopher H. Evans,Alison J. Morton,Mathew Winter,Michael J. Dark,David M. Nickerson,Patrick T. Colahan,Steven C. Ghivizzani +20 more